Manage subscription Reset Password

About Us

Are you concerned about the integrity of your supply chain? Perhaps you have already encountered counterfeit or mislabeled copies of your brands in the marketplace? With the WHO estimating that as much as 30 per cent of medicines circulating in the global marketplace are fake, it is likely that the answer to at least one of those questions is yes.

Until recently counterfeiting was perceived as being a problem that mainly affected markets with less well-regulated healthcare systems. But now drugmakers in mature markets are becoming increasingly exposed to sophisticated counterfeiting of their brands. And it seems this is no longer an issue affecting a handful of 'lifestyle' medicines: counterfeit copies of life-saving drugs for cancer, cardiovascular disease and central nervous system diseases have started to appear in the supply chains of even well-regulated markets.

SecuringPharma.com is a free-to-access information service that covers the issues surrounding supply chain and brand security in the pharmaceutical industry. The aim is to provide practical advice and intelligence to help manufacturers define and pursue their own strategies for tackling the problem. We cover key developments in:

authentication, verification and track-and-trace technologies
the regulatory environment;
issues relating to corporate liability;
the evolution of data standards;
drug pedigrees;
legal options to tackle the counterfeiters; and much more.

Key features

SecuringPharma.com is the only dedicated and centralised source of breaking news, market intelligence and technical information to help pharmaceutical manufacturers enhance the security of their supply chain. Key features include:

In-house editorial - in text, audio and video formats - that is researched and updated on a daily basis by specialist industry journalists and guest writers;
A regularly updated feed of important news and features from the global press. Our editorial team identifies the most important published information so you don't have to;
A product and service "showcase" to help you identify and compare relevant products and services;
A directory of relevant, targeted market research reports; and
A focused events calendar highlighting the key conferences and exhibitions covering pharmaceutical counterfeiting and supply chain security.

At SecuringPharma.com we believe that the problem of counterfeit medicines and supply chain security - from starting materials to the patient - is one of the most pressing issues affecting the pharmaceutical industry today. Securing patient safety is the ultimate goal, and by taking a proactive stance on the issue pharmaceutical companies have the opportunity to protect their revenues and their reputations.

Features
Papers & Media
Research
Events

EC seeks comment on unique medicine identifiers
The European Commission has published a concept paper on the unique identifier for medicines, outlined in the EU falsified medicines directive and due to be fleshed out via the delegated acts process.
WHO working group drafts resolution on SSFFC medicines
Last week's meeting of a WHO working group on low quality and illegal drugs ended with a draft resolution for debate at the next World Health Assembly.
FDA finalises guidance for on-dose anti-counterfeit technologies
The US FDA has published its final guidance on the use of on-dose anti-counterfeiting technologies - referred to as physicochemical identifiers or PCIDs - for use in solid oral dosage forms such as tablets and capsules.
Pangea IV nets illegal medicines worth around $6.3m
The latest Interpol-backed offensive against illegal medicines has led to 55 arrests and seizures of 2.4m potentially harmful drugs worth around $6.3m.
FDA report models counterfeiting and diversion patterns in US
A new report form the US Food and Drug Administration (FDA) has used historical cases of medicine counterfeiting and diversion to gain a better understanding of the methods used by criminals and help prevent incidents in future.